Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Peringkat dalam Saham #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Universitรฉ de Montrรฉal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Harga Saham
$0.14942078
Terakhir disinkronkan: 2025-05-15
Kapitalisasi Pasar
$3.86M
Perubahan (1 hari)
0.10%
Perubahan (1 tahun)
0.00%
Negara
DE
Perdagangan Medigene AG (MDG1)

Kategori

Laba untuk Medigene AG (MDG1)
Laba pada Jun 2024 TTM: $-16.77M
Menurut laporan keuangan terbaru dari Medigene AG, laba saat ini perusahaan adalah $-16.77M. Pada tahun 2022, perusahaan memperoleh laba sebesar $-10.06M, peningkatan dibandingkan laba tahun 2021 sebesar $-11.69M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Medigene AG dari 2004 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $-16.77M -8.57%
2023 $-18.34M 82.41%
2022 $-10.06M -14.01%
2021 $-11.69M -66.20%
2020 $-34.59M 54.79%
2019 $-22.35M -10.30%
2018 $-24.91M 60.47%
2017 $-15.53M 51.81%
2016 $-10.23M -33.71%
2015 $-15.43M 115.69%
2014 $-7.15M -49.32%
2013 $-14.11M -27.68%
2012 $-19.52M -2.57%
2011 $-20.03M -44.87%
2010 $-36.34M 15.53%
2009 $-31.45M -31.91%
2008 $-46.19M 0.82%
2007 $-45.82M 357.81%
2006 $-10.01M -29.67%
2005 $-14.23M -17.13%
2004 $-17.17M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$5.27B -31,555.72%
US
$1.95B -11,732.28%
NL
- -
CH
- -
KR
$3.01B -18,023.94%
BE